1. Anuncie Aqui ! Entre em contato fdantas@4each.com.br

The Uncertain Path Forward for Psychedelic Medicine

Discussão em 'Noticias' iniciado por Emily Mullin, Agosto 15, 2024.

  1. Emily Mullin

    Emily Mullin Guest

    After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company.

    Continue reading...

Compartilhe esta Página